Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastrointest Endosc. Oct 16, 2014; 6(10): 493-498
Published online Oct 16, 2014. doi: 10.4253/wjge.v6.i10.493
Table 1 Baseline characteristics of patients with colon polyps removed by endoscopic mucosal resection n (%)
n = 3015
Age, mean ± SD, yr59.6 ± 10.4
Male1771 (70.0)
Comorbidity
Hypertension564 (18.7)
Cardiovascular or cerebrovascular disease389 (12.9)
Chronic renal failure23 (0.8)
Liver cirrhosis75 (2.5)
Diabetes mellitus157 (5.2)
Cancer history353 (11.7)
Anti-coagulants and anti-platelets
Aspirin253 (8.3)
Clopidogrel57 (1.9)
Warfarin43 (1.4)
Size of lesion, mean ± SD, mm11.1 ± 6.8
Locations
Right side colon1296 (43.0)
Cecum109 (3.6)
Ascending colon805 (26.7)
Transverse colon382 (12.7)
Left side colon1719 (57.0)
Descending colon346 (11.5)
Sigmoid colon817 (25.9)
Rectum556 (18.4)
Morphologic classification
Pedunculated type550 (18.2)
Piecemeal resection130 (4.3)
Pathologic complete resection2956 (98.0)
Horizontal margin involvement31 (1.0)
Vertical margin involvement10 (0.3)
Serious immediate bleeding178 (2.6)
Prophylactic hemostatic clipping345 (11.4)
Delayed bleeding25 (0.8)
Spurting, n2
Oozing, n13
Clots with or without vessel exposure, n10
Onset of delayed post-EMR bleeding, mean ± SD (range), h9.9 ± 0.4
(7-72)
Perforation6 (0.2)
Histology
Adenoma2357 (78.2)
Tubular adenoma2026 (67.2)
Tubulovillous adenoma233 (7.7)
Villous adenoma99 (3.3)
Serrated adenoma66 (2.2)
Carcinoma89 (3.0)
Submucosal invasive carcinoma10 (0.3)
Hyperplastic polyp413 (13.6)
Others90 (3.0)
Table 2 Comparison between the delayed bleeding group and the uneventful group n (%)
Delayed bleeding n = 25Uneventful group n = 2990P value
Age, mean ± SD, yr58.4 ± 10.159.6 ± 10.40.646
Male15 (60.0)1756 (58.7)0.898
Laboratory before EMR
Hemoglobin, g/dL13.2 ± 1.413.66 ± 1.80.187
Platelet, × 103 count/mm360.5 ± 12.171.9 ± 1.30.81
Prothrombin time, INR0.984 ± 0.0670.989 ± 0.5280.785
Activated partial thromboplastin time, s33.8 ± 4.434.9 ± 23.20.665
Comorbidity
Hypertension5 (20.0)559 (18.7)0.800
Cardiovascular or cerebrovascular disease5 (20.0)384 (12.8)0.362
Chronic renal failure2 (8.0)21 (0.7)0.015
Liver cirrhosis1 (4.0)74 (2.5)0.131
Diabetes mellitus3 (12.0)154 (5.1)0.140
Cancer history3 (12.0)350 (11.7)1.000
Anti-coagulants and anti-platelets
Aspirin3 (12.0)250 (8.4)1.000
Clopidogrel1 (4.0)56 (1.9)0.381
Warfarin0 (0.0)43 (1.4)1.000
Size of lesion, mean ± SD, mm25.8 ± 11.611.0 ± 6.6< 0.001
Locations
Right side colon18 (32.0)1288 (43.1)0.314
Morphologic classification
Pedunculated11 (44.0)539 (18.0)0.003
Piecemeal resection6 (24.0)124 (4.1)0.001
Pathologic complete resection25 (100.0)2954 (79.9)1.000
Horizontal margin involvement0 (0.0)31 (1.0)1.000
Vertical margin involvement0 (0.0)10 (0.3)1.000
Serious immediate bleeding23 (12.0)75 (2.5)0.025
Prophylactic hemostatic clipping4 (16.0)341 (11.4)0.319
Histology
Adenoma23 (92.0)2337 (78.2)0.140
Carcinoma1 (4.0 )88 (18.4)0.529
Hyperplastic polyp1 (4.0)412 (13.8)0.240
Others0 (0.0)90 (3.0)1.000
Table 3 Multivariate analysis to define independent risk factors for delayed bleeding
OR95%CIP value
Size1.12911.096-1.164< 0.001
Pedunculated type1.4970.634-3.5340.357
Immediate serious bleeding9.1500.591-3.5060.413
Piecemeal resection2.2650.815-6.2920.117
Chronic renal failure9.1501.856-45.1060.007
Immediate post-EMR bleeding21.4470.597-3.5060.413